Reaction equation
[CH3:1][C:2]1([CH3:20])[O:6][C@@H:5]([C:7]2[N:8]=[CH:9][C:10]([NH:13]C(=O)C(C)(C)C)=[N:11][CH:12]=2)[CH2:4][O:3]1.C(=O)([O-])[O-].[K+].[K+]>CO>[CH3:1][C:2]1([CH3:20])[O:6][C@@H:5]([C:7]2[N:8]=[CH:9][C:10]([NH2:13])=[N:11][CH:12]=2)[CH2:4][O:3]1Participants
Conditions
- Temperature
- 25 °C
Procedure
A mixture of N-[5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-yl]-2,2-dimethyl-propionamide (8.4 g, 30.7 mmol) and potassium carbonate (4.32 g, 31.2 mmol) in methanol (150 mL) was stirred at 25° C. for 16.5 h, at which time, thin layer chromatography suggested partial conversion to a more polar product. In an effort to avoid epimerization at the stereogenic center, the reaction was discontinued before completion. Therefore, the solvent was removed under reduced pressure at 25° C. The resulting residue was again concentrated in vacuo from ethyl acetate (50 mL). The material was purified using Biotage chromatography (FLASH 40L, Silica, ethyl acetate). The early fractions collected allowed for the recovery of unreacted starting pivaloylamide as a white solid (2.0 g, 24%). The later fractions were concentrated in vacuo to provide 5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine (3.7 g, 63%) as a pale yellow oil. High-performance liquid chromatography analysis with a chiral column indicated 100% ee.
Workup
- customTherefore, the solvent was removed under reduced pressure at 25° C
- concentrationThe resulting residue was again concentrated in vacuo from ethyl acetate (50 mL)
- customThe material was purified
- customThe early fractions collected
- concentrationThe later fractions were concentrated in vacuo
Sources & evidence
- ORD record
- ord-c2184ca025d24d44ac3d7c2bf2d7f605
- Source dataset
- uspto-grants-2006_11
- Patent number
- US07132425B2
Linked notes
Loading…